The units are expected to be listed on the Nasdaq Global Market (Nasdaq) and trade under the ticker symbol “VACHU” August 9, 2024. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “VACH” and “VACHW”, respectively. The underwriters have been granted a 45-day option to purchase up to an additional 3,300,000 units offered by the Company to cover over-allotments, if any.
The Company intends to focus its target search on healthcare and healthcare-related industries, focusing on businesses with enterprise values between $160 million and $2 billion.
The Appleby corporate team included Partner Simon Raftopoulos and Senior Associate Alexandra Low.
